Igs as modifiers of the p53 pathway and methods of use
CA 2449136 A1 · Owner: Francis-Lang, Helen · Inventors: Plowman, Gregory D.; Friedman, Lori; Belvin, Marcia
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Human IG genes are identified as modulators of the p53 pathway and thus are , therapeutic targets for disorders associated with defective p53 function. Methods for identifying modulators of p53 comprising screening for agents , that modulate the activity of IG are provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 3, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 3, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 3, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.